Tuesday, July 16, 2024

CATEGORY

Pharmacoeconomics

Medicine Proposal by Pharmac to Increase Access for Cancer and Other Health Conditions

Medicines for various cancers, including kidney and lung cancers, as well as other health conditions, are being targeted for increased access by Pharmac –...

Liquidity Crisis in Iran’s Pharmaceutical Sector: Challenges for Drug Manufacturers and Importers

Iran's pharmaceutical sector is facing significant liquidity challenges, affecting both drug manufacturers and importers. Gholamhossein Sadeghian, Director General of Drugs at the Food and...

Medications on Iran’s Official Drug List Crucial for Patient Safety and Effective Treatment

The Secretary of the Committee for Reviewing and Compiling Iran's Drug List, Nazila Yousefi, has advised physicians to refrain from prescribing medications that are...

Generic Medicines and Biosimilars Take Center Stage at Tunisia’s Inaugural International Days

The Tunisian Association of Generic Medicines, in collaboration with the Ministry of Health, organized the First International Days of Generic Medicines and Biosimilars in...

BIOSECURE Act Could Impact US Biopharmaceutical Drugs with Half in Clinical Trials

The BIOSECURE Act could affect over 120 US biopharmaceutical drugs partnered with Chinese companies named in the bill as “companies of concern.” Of these,...

Vertex Expected to Solidify Dominance in Cystic Fibrosis Market with Vanza Triple Approval

Vertex Pharmaceuticals is anticipated to solidify its leading position in the cystic fibrosis (CF) therapy market with the submission of regulatory marketing applications for...

Pharmaceutical Price Reduction Focus of New Prime Therapeutics and Magellan Rx Partnership

Pharmaceutical price reduction is the focus of a new partnership announced by Prime Therapeutics and Magellan Rx Management, which will launch a pharmaceutical platform...

Iran Plans to Increase Pharmaceutical Exports by 30% in 2024, Aiming for Long-Term Growth

The Head of the Export Department at the General Directorate of Pharmaceuticals and Controlled Substances in Iran, Seyed Ali Maboudi, announced a mid-term plan...

Medical Sector in Iran Receives 6000 Billion Toman to Settle Debts Under Darouyar Scheme

The payment of 6000 billion Toman to pharmacies and medical centers' in Iran is claimed under the Darouyar scheme and has been announced by...

Drug Pricing and Health Care: Understanding the Impact of the Inflation Reduction Act

Drug pricing was a key topic during a recent webinar hosted by the Drug Channels Institute, where Adam Fein, PhD, discussed the specifics of...

Latest news